RPG Life Sciences Limited
RPG Life Sciences is holding an earnings call on April 30, 2026, at 3:30 PM IST. The call will cover the company's audited financial results for Q4 FY26 and the period ended March 31, 2026, with an investor presentation to follow.
Apr 23 2026 21:04:00
RPG Life Sciences Limited
RPG Life Sciences is holding an earnings call on April 30, 2026, at 3:30 PM IST. The call will cover the company's audited financial results for Q4 FY26 and the period ended March 31, 2026, with an investor presentation to follow.
Apr 23 2026 21:04:00
RPG Life Sciences Limited
RPG Life Sciences board will convene on April 29, 2026, to review and approve its audited standalone and consolidated financial results for the year ended March 2026. The meeting will also include consideration for recommending a final dividend.
Apr 22 2026 19:04:00
RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Of The Company Is Scheduled On 29Th April, 2026
RPG Life Sciences' Board will meet on April 29, 2026, to approve audited financial results for Q4 FY26 and the full FY26. The meeting will also consider recommending a dividend for the financial year ended March 31, 2026.
Apr 22 2026 19:04:00
RPG Life Sciences Ltd - 532983 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Clarus Capital I, a scheme of Clarus Trust, and PAC ClearEdge LLC acquired 0.88% equity in RPG Life Sciences Limited via open market. This increased their aggregate shareholding to 5.41%, crossing the disclosure threshold.
Apr 20 2026 13:04:00
RPG Life Sciences Limited
RPG Life Sciences initiated 'Saksham Niveshak' campaign to help shareholders claim unpaid dividends and update KYC details. This campaign follows an IEPFA directive from March 27, 2026, aimed at improving investor compliance.
Apr 06 2026 19:04:00
Read More